Literature DB >> 17347014

Allelic variation in BTNL2 and susceptibility to tuberculosis in a South African population.

Marlo Möller1, Ruta Kwiatkowski, Almut Nebel, Paul D van Helden, Eileen G Hoal, Stefan Schreiber.   

Abstract

Tuberculosis and sarcoidosis show phenotypic features of granulomatous disease. The bacterium Mycobacterium tuberculosis can induce the expression of the sarcoidosis susceptibility gene BTNL2 in monocyte-derived macrophages. BTNL2 was therefore investigated as a candidate gene for tuberculosis in a case-control association study in the South African Coloured population. We sequenced the coding regions of BTNL2 to detect known and novel polymorphisms and genotyped 18 SNPs in 432 pulmonary tuberculosis cases and 482 controls. We did not find a significant association between the truncating rs2076530 SNP, previously associated with sarcoidosis, and tuberculosis. No association was found between any of the other SNPs studied and disease and none of the estimated haplotypes showed any association with TB. Comparative analyses with the South African data from this study and published data on German and American populations revealed that, for a segment of BTNL2, the admixed, but not stratified, South African population resembles the African-Americans more than white populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347014     DOI: 10.1016/j.micinf.2007.01.011

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  10 in total

1.  Association of variants in BAT1-LTA-TNF-BTNL2 genes within 6p21.3 region show graded risk to leprosy in unrelated cohorts of Indian population.

Authors:  Shafat Ali; Rupali Chopra; Shweta Aggarwal; Amit Kumar Srivastava; Ponnusamy Kalaiarasan; Dheeraj Malhotra; Sailesh Gochhait; Vijay K Garg; S N Bhattacharya; Rameshwar N K Bamezai
Journal:  Hum Genet       Date:  2011-11-10       Impact factor: 4.132

Review 2.  Gatekeepers of intestinal inflammation.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Inflamm Res       Date:  2010-01       Impact factor: 4.575

3.  BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice.

Authors:  Xiaohong Tian; Yujun Lin; Cheng Cui; Min Su; Laijun Lai
Journal:  Adv Healthc Mater       Date:  2019-03-18       Impact factor: 9.933

Review 4.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

5.  In vivo administration of recombinant BTNL2-Fc fusion protein ameliorates graft-versus-host disease in mice.

Authors:  Cheng Cui; Xiaohong Tian; Yujun Lin; Min Su; Qingquan Chen; Shao-Yuan Wang; Laijun Lai
Journal:  Cell Immunol       Date:  2018-10-26       Impact factor: 4.868

6.  Genome-wide analysis of the structure of the South African Coloured Population in the Western Cape.

Authors:  Erika de Wit; Wayne Delport; Chimusa E Rugamika; Ayton Meintjes; Marlo Möller; Paul D van Helden; Cathal Seoighe; Eileen G Hoal
Journal:  Hum Genet       Date:  2010-05-20       Impact factor: 5.881

7.  Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.

Authors:  Yves Pacheco; Alain Calender; Dominique Israël-Biet; Pascal Roy; Serge Lebecque; Vincent Cottin; Diane Bouvry; Hilario Nunes; Pascal Sève; Laurent Pérard; Gilles Devouassoux; Nathalie Freymond; Chahira Khouatra; Benoît Wallaert; Raphaelle Lamy; Mad-Hélénie Elsensohn; Claire Bardel; Dominique Valeyre
Journal:  Orphanet J Rare Dis       Date:  2016-12-03       Impact factor: 4.123

8.  The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants.

Authors:  Xiang Tong; Yao Ma; Xundong Niu; Zhipeng Yan; Sitong Liu; Bo Peng; Shifeng Peng; Hong Fan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 9.  Novel Immune Check-Point Regulators in Tolerance Maintenance.

Authors:  Yanxia Guo; Adele Y Wang
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561

Review 10.  Butyrophilins: an important new element of resistance.

Authors:  Magdalena Malinowska; Beata Tokarz-Deptuła; Wiesław Deptuła
Journal:  Cent Eur J Immunol       Date:  2017-12-30       Impact factor: 2.085

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.